Advertisement
New Zealand markets closed
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NZD/USD

    0.5952
    +0.0002 (+0.04%)
     
  • NZD/EUR

    0.5561
    +0.0021 (+0.38%)
     
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • OIL

    83.76
    +0.19 (+0.23%)
     
  • GOLD

    2,351.90
    +9.40 (+0.40%)
     
  • NASDAQ

    17,699.90
    +269.39 (+1.55%)
     
  • FTSE

    8,140.53
    +61.67 (+0.76%)
     
  • Dow Jones

    38,260.70
    +174.90 (+0.46%)
     
  • DAX

    18,186.62
    +269.34 (+1.50%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • NZD/JPY

    93.4520
    +0.9560 (+1.03%)
     

What Analysts Recommend for Hologic ahead of Third-Quarter Results

What Analysts Recommend for Hologic ahead of Third-Quarter Results

Hologic (HOLX), a leading women’s health technology player, will release its fiscal third-quarter earnings results on July 31 after markets close. The stock fell more than 9% following the results. Many analysts covering Hologic cut their target prices on HOLX stock in the following days. As of July 30, Reuters reported that of the 19 analysts covering Hologic, ~63% have a “buy” or “strong buy” rating on HOLX stock.